TNFRSF11A and acute myeloid leukemia: Based on our finding that RANK affects AML cell viability, we next analyzed whether signaling via RANK also affects resistance of the leukemic cells to treatment with doxorubicin and cytarabine, the most commonly used chemotherapeutics utilized for treatment of AML.